Clinical Trial Update: Dolutegravir in Pregnant HIV Mothers and Their Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dolutegravir in pregnant people with HIV and neonatal outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: University of Liverpool | Conditions: HIV-1-infection, Pregnancy Related | Phase 3 | Status: COMPLETED